Glynib (imatinib) 100mg 12*10 Capsules

Doctors prescribe it as a once or twice daily oral capsule taken with food.

Glynib 100mg Capsule Ingredients and Usage

Glynib 100mg Capsule contains imatinib mesylate, a small molecule tyrosine kinase inhibitor. Doctors prescribe it for Philadelphia chromosome positive chronic myeloid leukemia in chronic, accelerated, or blast crisis phase, and for Philadelphia chromosome positive acute lymphoblastic leukemia in combination with chemotherapy.

Glynib 100mg Capsule also treats unresectable or metastatic gastrointestinal stromal tumors, certain myelodysplastic and myeloproliferative diseases, systemic mastocytosis, and hypereosinophilic syndrome. Dosing varies widely by condition, and treatment is guided by a specialist experienced in these disorders.

How Does Glynib 100mg Capsule Work?

Imatinib inhibits the Bcr-Abl tyrosine kinase, an abnormal enzyme produced by the Philadelphia chromosome that drives uncontrolled white blood cell growth in chronic myeloid leukemia. It also inhibits related kinases, including KIT and platelet derived growth factor receptors.

By blocking these kinases, Glynib 100mg Capsule stops the proliferation signal that keeps cancer cells dividing and triggers apoptosis, or programmed cell death, in cells that depend on this abnormal signaling. This targeted mechanism underlies its activity across leukemia, GIST, and other kinase driven conditions.

Glynib 100mg Capsule Side Effects

Glynib 100mg Capsule commonly causes digestive, fluid retention, and general side effects.

• Nausea and vomiting

• Diarrhea

• Muscle cramps and musculoskeletal pain

• Fluid retention, causing swelling around the eyes or in the legs

• Fatigue

• Skin rash

• Headache

Warnings

• Glynib 100mg Capsule can cause severe fluid retention, including pleural effusion and pulmonary edema; monitor for unexplained weight gain, swelling, or shortness of breath.

• The medicine can cause hepatotoxicity; liver function tests should be checked before starting treatment and monitored monthly, with dose adjustment or interruption if bilirubin or transaminases rise significantly.

• Glynib 100mg Capsule can lower blood cell counts, increasing the risk of infection and bleeding; complete blood counts should be monitored weekly for the first month and periodically thereafter.

• Gastrointestinal hemorrhage and, rarely, gastrointestinal perforation have been reported; report severe abdominal pain or signs of bleeding promptly.

• Glynib 100mg Capsule can cause fetal harm and is contraindicated in pregnancy; use effective contraception during treatment and for at least 14 days after the last dose.

• Avoid grapefruit juice and strong CYP3A4 inhibitors or inducers, since these significantly alter imatinib blood levels; use caution with other CYP3A4 substrates such as certain statins and calcium channel blockers.

• Warfarin should not be used with Glynib 100mg Capsule; low molecular weight or standard heparin is preferred for patients requiring anticoagulation.

Glynib 100mg Capsule Storage Conditions

Store Glynib 100mg Capsule at room temperature, away from direct sunlight, heat, and moisture. Keep capsules in their original packaging until the dose is due. Store this medicine out of reach of children and dispose of any expired or unused capsules according to local pharmacy guidelines.